Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) are more susceptible to retinal ischemic injury in vivo.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) are more susceptible to retinal ischemic injury in vivo.
- Published In:
- Neurotoxicity research, 21(1), 41-8 (2012)
- Authors:
- Szabadfi, K, Atlasz, T, Kiss, P, Danyadi, B, Tamas, A, Helyes, Zs, Hashimoto, H, Shintani, N, Baba, A, Toth, G, Gabriel, R, Reglodi, D
- Database ID:
- RPEP-02082
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02082APA
Szabadfi, K; Atlasz, T; Kiss, P; Danyadi, B; Tamas, A; Helyes, Zs; Hashimoto, H; Shintani, N; Baba, A; Toth, G; Gabriel, R; Reglodi, D. (2012). Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) are more susceptible to retinal ischemic injury in vivo.. Neurotoxicity research, 21(1), 41-8. https://doi.org/10.1007/s12640-011-9254-y
MLA
Szabadfi, K, et al. "Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) are more susceptible to retinal ischemic injury in vivo.." Neurotoxicity research, 2012. https://doi.org/10.1007/s12640-011-9254-y
RethinkPeptides
RethinkPeptides Research Database. "Mice deficient in pituitary adenylate cyclase activating pol..." RPEP-02082. Retrieved from https://rethinkpeptides.com/research/szabadfi-2012-mice-deficient-in-pituitary
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.